GlobeNewswire Inc.·4h ago·NaCardiff Oncology to Present Onvansertib Phase 2 Data at ASCO 2026Cardiff Oncology will present updated Phase 2 data for onvansertib in RAS-mutated colorectal cancer at ASCO 2026 in June. CRDFcolorectal cancerphase 2 trial
GlobeNewswire Inc.··Na